TransMedics Group, Inc. Detailed Financials

Full historical quarterly statements

Metric	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Total Revenue	173.9M	160.8M	143.8M	157.4M	143.5M	121.6M	108.8M	114.3M
Cost of Goods Sold	72.8M	67.3M	59.2M	60.8M	55.3M	49.6M	47.9M	45.1M
Gross Profit	101.2M	93.4M	84.6M	96.6M	88.2M	72.0M	60.8M	69.2M
R&D Expenses	24.9M	20.7M	15.3M	15.9M	17.2M	16.5M	14.3M	13.9M
Operating Expenses	87.9M	72.1M	61.3M	60.0M	60.8M	63.4M	56.9M	56.7M
Operating Income	13.3M	21.3M	23.3M	36.6M	27.4M	8.6M	3.9M	12.5M
Other Income / Gains	-4.8M	360K	-269K	-385K	-767K	-1.7M	322K	-355K
Net Income	7.3M	105.4M	24.3M	34.9M	25.7M	6.9M	4.2M	12.2M
EPS (Diluted)	0.21	3.08	0.71	1.03	0.76	0.20	0.13	0.37
Reported Currency	USD	USD	USD	USD	USD	USD	USD	USD
Gross Profit Ratio	0.582	0.581	0.588	0.614	0.615	0.592	0.559	0.605
General And Administrative Expenses	0	50.2M	44.9M	44.1M	43.6M	46.9M	42.7M	42.9M
Selling And Marketing Expenses	0	1.3M	1.1M	0	0	0	0	-100K
Selling General And Administrative Expenses	63.0M	51.4M	46.0M	44.1M	43.6M	46.9M	42.7M	42.8M
Other Expenses	0	0	0	0	0	0	0	0
Cost And Expenses	160.6M	139.5M	120.5M	120.8M	116.1M	113.0M	104.8M	101.8M
Interest Income	3.0M	0	0	2.5M	0	2.9M	3.3M	3.4M
Interest Expense	7.2M	3.4M	3.5M	3.5M	3.5M	3.6M	3.6M	3.6M
Depreciation And Amortization	11.9M	7.5M	6.8M	6.7M	6.1M	5.7M	5.2M	4.6M
Ebitda	25.2M	32.5M	33.4M	46.4M	36.3M	16.2M	13.0M	20.4M
Ebitdaratio	0.145	0.202	0.232	0.295	0.253	0.134	0.12	0.178
Operating Income Ratio	0.076	0.132	0.162	0.232	0.191	0.071	0.036	0.109
Income Before Tax	8.5M	21.6M	23.0M	36.2M	26.7M	7.0M	4.2M	12.2M
Income Before Tax Ratio	0.049	0.135	0.16	0.23	0.186	0.057	0.039	0.106
Income Tax Expense	1.2M	-83.8M	-1.3M	1.3M	994K	132K	29K	-41K
Net Income Ratio	0.042	0.656	0.169	0.222	0.179	0.056	0.039	0.107
Epsdiluted	0.20	2.59	0.66	0.92	0.70	0.19	0.12	0.35
Weighted Average Shs Out	34.4M	34.2M	34.1M	33.9M	33.7M	33.6M	33.4M	33.1M
Weighted Average Shs Out Dil	36.2M	40.9M	40.7M	40.6M	39.9M	35.2M	35.7M	35.3M